PharmaFox (PhFx) develops biologicals for the treatment of muscle disorders. PhFx has obtained strong preclinical proof of concept with its proprietary compound increasing muscle strength and endurance in mice. PhFx is preparing for Phase I studies and looking for its first round of investment


Untere Fuchsrainstrasse 16, 4313 Möhlin, Switzerland

Facts & figures
  • Type of organization

    Private company

  • Year of foundation


  • Number of employees in Switzerland


Key business